Ana Paula Junqueira-Kipnis

Ana Paula Junqueira-Kipnis

Auto-generated profile, based on publicly available information

Ana Paula Junqueira-Kipnis

Departamento de Microbiologia Imunologia Parasitologia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2007 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MRMarcelo Fouad Rabahi
Marcelo Fouad Rabahi
AJAna Paula Junqueira-Kipnis
Ana Paula Junqueira-Kipnis
MRMichelle Cristina Guerreiro dos Reis
Michelle Cristina Guerreiro dos Reis
WOWalter Oelemann
Walter Oelemann
MCMarcus Barreto Conde
Marcus Barreto Conde
Background: Tuberculosis (TB) remains a major world health problem. Around 2 billions of people are infected by Mycobacterium tuberculosis, the causal agent of this disease. This fact accounts for a third of the total world population and it is expected that 9 million people will become infected each year. Only approximately 10% of the infected people will develop disease. However, health care workers (HCW) are continually exposed to the bacilli at endemic sites presenting increased chance of becoming sick. The objective of this work was to identify LTBI (latent tuberculosis infection) among all asymptomatic HCW of a Brazilian Central Hospital, in a three year follow up, and evaluate the humoral response among HCW with previous and recent LTBI to recombinant HspX and GlcB from M. tuberculosis. Methods: Four hundred and thirty seven HCW were screened and classified into three different groups according to tuberculin skin test (TST) status: uninfected, previous LTBI and recent LTBI. ELISA test were performed to determine the humoral immune response to HspX and GlcB. Results: The levels of IgG and IgM against the HspX and GlcB antigens were the same among HCW with recent and previous LTBI, as well as among non infected HCW. However, the IgM levels to HspX was significantly higher among HCW with recent LTBI (OD = 1.52 ± 0.40) than among the uninfected (OD = 1.09 ± 0.50) or subjects with previous LTBI (OD = 0.96 ± 0.51) (p < 0.001). Conclusion: IgG and IgM humoral responses to GlcB antigens were similar amongst all studied groups; nevertheless IgM levels against HspX were higher among the recent LTBI/HCW.

1 April 2010 in Infection and Immunity
Verified
Journal Article
Open access
ESEduardo Martins de Sousa
Eduardo Martins de Sousa
FBFernando Bonfim de Bortoli
Fernando Bonfim de Bortoli
EAEduardo Pinheiro Amaral
Eduardo Pinheiro Amaral
ABAline Carvalho Batista
Aline Carvalho Batista
TKThereza Liberman Kipnis
Thereza Liberman Kipnis
AJAna Paula Junqueira-Kipnis
Ana Paula Junqueira-Kipnis
Mycobacterium massilienseis an environmental opportunistic pathogen that has been associated with soft tissue infection after minor surgery. We studied the acute immune response of C57BL/6 and BALB/c mice infected intravenously with 106CFU of anM. massiliensestrain isolated from a nosocomial infection in Brazil. The results presented here show thatM. massilienseis virulent and pathogenic to both C57BL/6 and BALB/c mice, inducing a granulomatous inflammatory reaction that involves the activation of macrophages, dendritic cells, and natural killer cells induced by gamma interferon and interleukin-17 (IL-17) in C57BL/6 mice and by IL-12 in BALB/c mice.

16 July 2009 in Vaccine
Verified
Journal Article
Closed access
BSBruna Daniella de Souza Silva
Bruna Daniella de Souza Silva
ESEdiane Batista da Silva
Ediane Batista da Silva
INIvan Pereira Do Nascimento
Ivan Pereira Do Nascimento
MRMichelle Cristina Guerreiro dos Reis
Michelle Cristina Guerreiro dos Reis
Ana Paula Junqueira-KipnisAna Paula Junqueira-Kipnis
Ana Paula Junqueira-Kipnis
AJAna Paula Junqueira-Kipnis
Ana Paula Junqueira-Kipnis

31 October 2010 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
LSLorena Cristina Santos
Lorena Cristina Santos
HBHesther de Macedo Bousquet
Hesther de Macedo Bousquet
APAlyne Melo Pereira
Alyne Melo Pereira
AJAna Paula Junqueira-Kipnis
Ana Paula Junqueira-Kipnis
Ana Paula Junqueira-KipnisAna Paula Junqueira-Kipnis
Ana Paula Junqueira-Kipnis

1 March 2008 in Clinical and Vaccine Immunology
Verified
Journal Article
Closed access
CACristina Melo Cardoso Almeida
Cristina Melo Cardoso Almeida
AVArioldo C. Vasconcelos
Arioldo C. Vasconcelos
Ana Paula Junqueira-KipnisAna Paula Junqueira-Kipnis
Ana Paula Junqueira-Kipnis
AAAna Lúcia Andrade
Ana Lúcia Andrade
AJAna Paula Junqueira-Kipnis
Ana Paula Junqueira-Kipnis
The humoral responses to recombinant MPT-51 and GlcB was determined by using an enzyme-linked immunosorbent assay. Levels of immunoglobulin M (IgM) against MPT-51 and IgG against GlcB were higher among tuberculosis (TB) patients than among control individuals. When the MPT-51 and GlcB assays were combined, 90.8% specificity and 75.5% sensitivity were observed. MPT-51 and GlcB were recognized in the humoral responses of Brazilian TB patients.

1 December 2011 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MRMichelle Cristina Guerreiro dos Reis
Michelle Cristina Guerreiro dos Reis
BSBruna Daniella de Souza Silva
Bruna Daniella de Souza Silva
Eduardo Martins de SousaEduardo Martins de Sousa
Eduardo Martins de Sousa
AJAna Paula Junqueira-Kipnis
Ana Paula Junqueira-Kipnis